Difference between revisions of "Deng Zhenling, et al. BMC Immunology (2015) cited as Ref 671 in DOI: 10.1038/s41392-020-0110-5 (Q9934)"
Jump to navigation
Jump to search
(Created claim: Fourth Author string (P152): Zhang Shuren, #quickstatements; #temporary_batch_1590155310798) |
(Created claim: Fifth Author string (P153): Zhang Yu-Qian, #quickstatements; #temporary_batch_1590155508986) |
||
| Property / Fifth Author string | |||
| + | Zhang Yu-Qian | ||
| Property / Fifth Author string: Zhang Yu-Qian / rank | |||
| + | Normal rank | ||
Latest revision as of 13:53, 22 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Deng Zhenling, et al. BMC Immunology (2015) cited as Ref 671 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Deng Zhenling
0 references
Wu Yanhong
0 references
Ma Wenbo
0 references
1
0 references
2015
0 references
BMC Immunology
0 references
16
0 references
Adoptive T-cell therapy of prostate cancer targeting the cancer stem cell antigen EpCAM (English)
0 references
1-
0 references
Zhang Shuren
0 references
Zhang Yu-Qian
0 references
